• Visitors can check out the Forum FAQ by clicking this link. You have to register before you can post: click the REGISTER link above to proceed. To start viewing messages, select the forum that you want to visit from the selection below. View our Forum Privacy Policy.
  • Want to receive the latest contracting news and advice straight to your inbox? Sign up to the ContractorUK newsletter here. Every sign up will also be entered into a draw to WIN £100 Amazon vouchers!

Brexit dividend

Collapse
X
  •  
  • Filter
  • Time
  • Show
Clear All
new posts

    Brexit dividend

    How uplifting to watch the UK march into the financial sunny uplands of a Brexit dividend fuelled NHS spending boom.

    https://www.theguardian.com/business...it-mark-boleat

    A leading City figure whose former role involved governing the Square Mile has said Brexit could result in the loss of 75,000 jobs and up to £10bn in annual tax revenue.

    Sir Mark Boleat, who was chairman of the City of London Corporation until last year, said a seepage of jobs from the capital was already underway and that the political rows over a deal or no-deal outcome was now “irrelevant” to City chief executives.

    Banks including JP Morgan, Lloyds, Barclays, HSBC and Goldman Sachs have already established subsidiaries in other EU countries, or moved part of their business because EU law requires them to be legally compliant from the day the UK leaves.

    “It is no longer contingency planning. If you are running a bank it is non-negotiable. The regulators won’t allow it,” he said.

    In an interview with the Guardian before a keynote speech on Wednesday at the Cass Business School in London, Boleat said the City would not die as the financial capital of Europe but would be damaged by Brexit.

    “These moves are bad for London, but they are also bad for the EU because they will make financial markets less efficient,” he said. “Financial services will be fine, but I would say if the City has 80% of international business now, in future it will have maybe 60%.”

    Boleat said Brexit has prompted expensive and unwelcome processes and the damage would be seen over the decade to come.

    “This is a 10-year operation. In the short term it won’t be noticeable in terms of staff. Banks won’t be putting out press releases saying they are moving some of their operations because of Brexit because they don’t want the publicity. They are just getting on with it.

    “Moving costs millions. Banks have had teams of 100 working on Brexit. It is an expensive process. You have to identify which city to go to, applying for a [banking] licence costs millions, then you have to find the IT staff, find accommodation.”

    He also believes the government is in such disarray that the Brexit deal will be pushed back to December, leaving business planning elsewhere perilously close to exiting the EU.

    In his address, Boleat will say he does not think financial services will get a special passporting deal to allow them to continue pan-European services from London and that banks are already past that moment of truth, whatever politicians think.

    “Those who suggested that some business would move were accused of scaremongering,” he will say before listing 15 major banks and financial services who have already set up on the continent or Dublin.

    He will quote a report by the Oliver Wyman consultancy that says if the UK strikes a deal giving full market access, the impact on the City would be modest, the equivalent of 3,000-4,000 jobs and a loss of £500m in tax a year to the Exchequer.

    “At the other end of the spectrum if the UK had no special status with the EU, now the most likely option, the industry would lost £18bn a year in revenue which would put 31,000 to 35,000 jobs at risk along with £3.5bn to £5bn in tax revenue.”

    Add the knock-on effect for related industries and the loss of entire business units, there is an estimated further losses of £14bn to £18bn in revenue and 34,000 to 40,000 jobs and £5bn in tax.

    Asked whether the government was aware of the daily bleed of financial services to the rest of the EU, Boleat said: “Not enough, that’s the worry. It needs business to talk to MPs, not to give their view on Brexit, but to explain to them ‘this is what I am having to do because of Brexit’. This is not scaremongering, this is reality.”

    #2
    Originally posted by Old Greg View Post
    How uplifting to watch the UK march into the financial sunny uplands of a Brexit dividend fuelled NHS spending boom.

    https://www.theguardian.com/business...it-mark-boleat
    Is your use of the word 'uplifting', meant to be conveyed in the same way JRM described foodbanks?
    Originally posted by Old Greg
    I admit I'm just a lazy, lying cretinous hypocrite and must be going deaf
    ♕Keep calm & carry on♕

    Comment


      #3
      Originally posted by Bean View Post
      Is your use of the word 'uplifting', meant to be conveyed in the same way JRM described foodbanks?
      You're on the ball today. Good work!

      Comment


        #4
        Originally posted by Old Greg View Post
        How uplifting to watch the UK march into the financial sunny uplands of a Brexit dividend fuelled NHS spending boom.

        https://www.theguardian.com/business...it-mark-boleat
        Same thing is happening in my sector: pharma/life sciences.
        On the plus side there are signicant strengths in research in UK universities. However that can be replicated elsewhere by simply poaching the best researchers.
        In the long term the sector will shrink in the UK, the only unknown is by how much - the UK is simply not as big a market as the EU, and the single payer NHS is under significant funding pressure, fake "Brexit dividend" notwithstanding.
        Many of the pharma consultancy cos are establishing offices in Brussels and Amsterdam, jobs that would otherwise have been created in the UK.
        Hard Brexit now!
        #prayfornodeal

        Comment


          #5
          The government's "vision" is simply to be "in office" so that they can keep their comfortable limousines and other perks.

          It's all pointing to a coup in the Spring to put Boris in charge after the UK has crashed out of the EU with what looks like will be a really sh*te deal.

          I'm alright Jack

          Comment


            #6
            Originally posted by sasguru View Post
            Same thing is happening in my sector: pharma/life sciences.
            On the plus side there are signicant strengths in research in UK universities. However that can be replicated elsewhere by simply poaching the best researchers.
            In the long term the sector will shrink in the UK, the only unknown is by how much - the UK is simply not as big a market as the EU, and the single payer NHS is under significant funding pressure, fake "Brexit dividend" notwithstanding.
            Many of the pharma consultancy cos are establishing offices in Brussels and Amsterdam, jobs that would otherwise have been created in the UK.
            On the plus side, a post-Brexit relaxation of ethical standards would provide economic opportunities as clinical trial volunteers for those Brexiteers too unfit to work on fruit farms or down the jam mines.

            Comment


              #7
              Originally posted by Old Greg View Post
              On the plus side, a post-Brexit relaxation of ethical standards would provide economic opportunities as clinical trial volunteers for those Brexiteers too unfit to work on fruit farms or down the jam mines.
              Sadly, the reality is that in the pharma market at least, the UK will have to sign up to the same standards as dictated by the EMA if UK or Japanese/other UK-based pharma companies are to market any drugs in the much larger and profitable EU market.
              The only effect Brexit will have on the pharma/life sciences sector in the UK is to shrink it - by how much we don't know yet.
              Hard Brexit now!
              #prayfornodeal

              Comment


                #8
                Originally posted by sasguru View Post
                Sadly, the reality is that in the pharma market at least, the UK will have to sign up to the same standards as dictated by the EMA if UK or Japanese/other UK-based pharma companies are to market any drugs in the much larger and profitable EU market.
                The only effect Brexit will have on the pharma/life sciences sector in the UK is to shrink it - by how much we don't know yet.
                I also find it interesting that the Brexiteers claim how trading under WTO rules with the EU will be no problem, whilst Trump complains that the US has been losing the trade war with the EU for decades.

                The EU will be taking the UK to the cleaners.

                I'm alright Jack

                Comment


                  #9
                  Originally posted by BlasterBates View Post
                  I also find it interesting that the Brexiteers claim how trading under WTO rules with the EU will be no problem, whilst Trump complains that the US has been losing the trade war with the EU for decades.

                  The EU will be taking the UK to the cleaners.

                  Tariffs on pharma products have been largely eliminated by 22 countries including all the EU and the US, because clearly they are a tax on the sick (the barriers in pharma are largely regulatory standards which is fair enough - you want to know your meds are safe).
                  But given Trump's actions so far, I full expect him to repudiate that agreement thus raising the price of medicines for everyone.
                  Hard Brexit now!
                  #prayfornodeal

                  Comment


                    #10
                    Originally posted by Old Greg View Post
                    How uplifting to watch the UK march into the financial sunny uplands of a Brexit dividend fuelled NHS spending boom.

                    https://www.theguardian.com/business...it-mark-boleat
                    Incredible that this is actually happening and has been for a while now yet the Brexiteers are still using the "Scaremongering" tactic.

                    Makes you wonder what the budget shortfall will be in 2023 and the effect on the individuals/companies that actually pay the most taxes.
                    Warning unicorn meat may give you hallucinations

                    Comment

                    Working...
                    X